{"id":"https://openalex.org/W4361958113","doi":"https://doi.org/10.1158/1078-0432.c.6524550.v1","title":"Data from A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors","display_name":"Data from A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361958113","doi":"https://doi.org/10.1158/1078-0432.c.6524550.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6524550.v1","doi":"https://doi.org/10.1158/1078-0432.c.6524550.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6524550.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6524550.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049243227","display_name":"Igor J. Puzanov","orcid":"https://orcid.org/0000-0002-9803-3497","observed_orcids":["https://orcid.org/0000-0002-9803-3497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Igor Puzanov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019052781","display_name":"Colin R. Lindsay","orcid":"https://orcid.org/0000-0001-8167-5461","observed_orcids":["https://orcid.org/0000-0001-8167-5461"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin R. Lindsay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088976086","display_name":"Laura Williams Goff","orcid":"https://orcid.org/0000-0001-6719-1479","observed_orcids":["https://orcid.org/0000-0001-6719-1479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Goff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110661316","display_name":"Jeff A. Sosman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeff Sosman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106038439","display_name":"Jill Gilbert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jill Gilbert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039492614","display_name":"Jordan D. Berlin","orcid":"https://orcid.org/0000-0001-7571-2385","observed_orcids":["https://orcid.org/0000-0001-7571-2385"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jordan Berlin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103019090","display_name":"Srinivasu Poondru","orcid":"https://orcid.org/0009-0002-8807-9894","observed_orcids":["https://orcid.org/0009-0002-8807-9894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Srinivasu Poondru","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071903899","display_name":"Ronit Simantov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronit Simantov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078915067","display_name":"Rich Gedrich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rich Gedrich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021075936","display_name":"Andrew Wills Stephens","orcid":"https://orcid.org/0000-0001-5052-6586","observed_orcids":["https://orcid.org/0000-0001-5052-6586","https://orcid.org/0000-0002-4434-2307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Stephens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102006912","display_name":"Emily W. Chan","orcid":"https://orcid.org/0000-0002-9955-5203","observed_orcids":["https://orcid.org/0000-0002-9955-5203"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5038656790","display_name":"Thomas R. Jeffry Evans","orcid":"https://orcid.org/0000-0002-4175-914X","observed_orcids":["https://orcid.org/0000-0002-4175-914X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T.R. Jeffry Evans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osi-906","display_name":"OSI-906","score":1.0},{"id":"https://openalex.org/keywords/igf1r-inhibitors","display_name":"IGF1R inhibitors","score":0.8569999933242798},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9380000233650208},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.906000018119812},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8450000286102295},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.9760000109672546},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8889999985694885},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.859000027179718},{"id":"https://openalex.org/keywords/insulin-receptor-phosphorylation","display_name":"insulin receptor phosphorylation","score":0.8149999976158142},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8679999709129333},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9399999976158142},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7609647512435913},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6059352159500122},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5893136262893677},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5652258396148682},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48545676469802856},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.42440733313560486},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4152739644050598},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37872427701950073},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3734600245952606}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6524550.v1","doi":"https://doi.org/10.1158/1078-0432.c.6524550.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6524550.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6524550.v1","doi":"https://doi.org/10.1158/1078-0432.c.6524550.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6524550.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2163205418","https://openalex.org/W4361945442","https://openalex.org/W2140498074","https://openalex.org/W2589293705","https://openalex.org/W2244796562","https://openalex.org/W2248901366","https://openalex.org/W2260254170","https://openalex.org/W2964703132","https://openalex.org/W2563667280","https://openalex.org/W2089069627"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"OSI-906":[2,34,81,155,229,244],"is":[3],"a":[4,46,63,68,160,205],"potent":[5],"inhibitor":[6],"of":[7,19,33,72,103,119,162,189,243],"insulin-like":[8],"growth":[9],"factor-1":[10],"receptor":[11,15],"(IGF1R)":[12],"and":[13,30,42,67,114,117,122,138,165,178,184,209,233],"insulin":[14],"(IR).":[16],"The":[17,59,128,143],"purpose":[18],"this":[20],"study":[21,52,60],"was":[22,45,148,156,222,230,236],"to":[23,132],"determine":[24],"the":[25,95,226],"MTD,":[26,228],"safety,":[27],"pharmacokinetics,":[28],"pharmacodynamics,":[29],"preliminary":[31],"activity":[32,235],"in":[35,53,94,245],"patients":[36,54,73,92,192],"with":[37,55,74,80,159,186,202],"advanced":[38,56],"solid":[39,57,246],"tumors.":[40,58,247],"Patients":[41,77],"Methods:":[43],"This":[44],"nonrandomized,":[47],"open-label,":[48],"phase":[49,145],"I,":[50],"dose-escalation":[51],"also":[61],"included":[62,107],"diabetic":[64],"expansion":[65,70],"cohort":[66,71],"biomarker":[69],"colorectal":[75],"cancer.":[76],"were":[78,130,169,181],"treated":[79],"by":[82,171,258],"once-":[83],"or":[84],"twice-daily":[85],"continuous":[86],"dosing":[87],"schedules.":[88],"Results:":[89],"Of":[90],"95":[91],"enrolled":[93],"study,":[96],"86":[97],"received":[98],"at":[99],"least":[100],"one":[101],"dose":[102,147],"OSI-906.":[104,190],"Dose-limiting":[105],"toxicities":[106],"QTc":[108],"prolongation,":[109],"grade":[110,126],"2":[111],"abdominal":[112],"pain":[113],"nausea,":[115],"hyperglycemia,":[116],"elevation":[118],"aspartate":[120],"aminotransferase":[121,124],"alanine":[123],"(all":[125],"3).":[127],"MTDs":[129],"established":[131,227],"be":[133],"400":[134],"mg":[135,140,152],"once":[136],"daily":[137],"150":[139,151],"twice":[141,153],"daily.":[142,154],"recommended":[144],"II":[146],"determined":[149],"as":[150,196],"rapidly":[157],"absorbed":[158],"half-life":[161],"5":[163],"hours,":[164],"steady-state":[166],"plasma":[167,187],"concentrations":[168,188],"achieved":[170],"day":[172],"8.":[173],"Pharmacodynamic":[174],"effects":[175],"on":[176],"IGF1R":[177],"IR":[179],"phosphorylation":[180],"levels":[182],"observed":[183],"correlated":[185],"Thirty-one":[191],"had":[193,204],"stable":[194],"disease":[195],"their":[197],"best":[198],"response.":[199],"One":[200],"patient":[201],"melanoma":[203],"radiographic":[206],"partial":[207],"response":[208],"underwent":[210],"resection,":[211],"during":[212],"which":[213],"only":[214],"melanocytic":[215],"debris":[216],"but":[217],"no":[218],"viable":[219],"tumor":[220],"tissue":[221],"identified.":[223],"Conclusions:":[224],"At":[225],"well":[231],"tolerated":[232],"antitumor":[234],"observed.":[237],"These":[238],"results":[239],"support":[240],"further":[241],"evaluation":[242],"Clin":[248],"Cancer":[249],"Res;":[250],"21(4);":[251],"701\u201311.":[252],"\u00a92014":[253],"AACR.":[254],"See":[255],"related":[256],"commentary":[257],"Yee,":[259],"p.":[260],"667":[261]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2023-04-05T00:00:00"}